7th Annual Pharmaceutical Portfolio And Lifecycle Management Conference, 18-19 April 2012, London

Main Category: Conferences
Article Date: 09 Feb 2012 - 0:00 PST


With declining R&D costs, prioritizing a portfolio of successful projects has become essential within the pharmaceutical industry. Lifecycle management approaches must be implemented throughout a market period to ensure an increase in profit. Ultimately, the success of pharmaceutical companies relies on crucial project portfolio decisions and understanding of a product's lifecycle.

Join SMi at their 7th annual Pharmaceutical Portfolio & Lifecycle Management conference that will address the challenges associated with obtaining an optimal portfolio of projects. Senior level industry executives will discuss key strategies and management approaches essential to effective portfolio and lifecycle management.


Reasons to attend include:

• Gain knowledge of how to successfully combine and implement multiple projects
• Examine ideas for Lifecycle management of the portfolio
• Measure portfolio value and risk
• Evaluate LCM - making the most of every brand!
• Assess early stage strategies and intellectual property
• Determine lifecycle management effectiveness
• Discover the importance of maximizing introduction, growth and maturity phases to increase revenue
• Network with top pharma companies and universities


Top speaker line up includes:


Tony Ellery, Managing Director, Ellery Pharma Consulting, Former Global Head LCM in Portfolio Management, Novartis


Kimber Hardy, Head of Valuation and Analysis, Merck Serono


Tim Harris, Director, Respiratory & Immuno-inflammation Portfolio Management, GlaxoSmithKline


Shafique Virani, Global Head CNS Business Development, F. Hoffman La Roche
Sakir Mutevelic, Head of Global Project Management Biopharmaceuticals Hemophilia A/WD, Baxter


Christiano Pereira Silva, Global Product Manager for Pradaxa, Boehringer-Ingelheim


Julie Barrett-Major, Director of Intellectual Property, Norgine


Alan S. Harris, Senior Vice President, Global Projects & Portfolio Management, Ferring Pharmaceuticals


Christine Deuschel, Vice President Portfolio & Project Management, Debiopharm


Anne Lane, Executive Director, University College London Business


For further details and to register visit http://www.smi-online.co.uk/pharma-portfolio36.asp alternatively contact Fateja Begum on tel +44 0207 827 6184

• Additional
• References
• Citations